Can Fam Physician. 1977 Oct;23:107-13.
The serum digoxin assay has become a popular laboratory test. However, its use is only appropriate if new information is gleaned which ultimately influences the physician's decision making. There are pitfalls inherent in the test if the technique is not standardized, or if the sample is taken randomly rather than at least 12 hours after the last dose of the drug. Moreover, therapeutic levels derived from adult patients in sinus rhythm cannot be applied to infants, nor to patients with atrial fibrillation.The development and use of the serum digoxin test has broadened awareness of digitalis pharmacokinetics. Its clinical implementation has occurred concurrently with other advancements in digitalis pharmacology such as bioavailability studies and the concept of low loading dosage. Together, all these factors have had an educational effect on physicians and lowered the frequency of digitalis toxicity.The physician must consider the complete patient in his total clinical milieu, and not treat only a laboratory result, i.e. the serum digoxin level.
血清地高辛检测已成为一种常用的实验室检测手段。然而,只有当新的信息被获取并最终影响医生的决策时,该检测才具有实际意义。如果检测技术没有标准化,或者样本是在最后一次给药后至少 12 小时之前采集的,而不是随机采集的,那么该检测存在固有缺陷。此外,从窦性心律的成年患者中得出的治疗水平不能应用于婴儿,也不能应用于房颤患者。血清地高辛检测的发展和应用拓宽了人们对地高辛药代动力学的认识。它的临床应用与地高辛药理学的其他进展同时发生,如生物利用度研究和低负荷剂量的概念。所有这些因素都对医生产生了教育作用,降低了地高辛毒性的发生频率。医生必须考虑患者的整体情况,而不仅仅是治疗实验室结果,即血清地高辛水平。